{"id":9873,"date":"2020-04-02T15:34:07","date_gmt":"2020-04-02T13:34:07","guid":{"rendered":"https:\/\/www.inmi.it\/?page_id=9873"},"modified":"2020-04-17T10:32:30","modified_gmt":"2020-04-17T08:32:30","slug":"protocollo-clinico-e-terapeutico-pazienti-covid-19","status":"publish","type":"page","link":"https:\/\/www.inmi.it\/pt\/protocollo-clinico-e-terapeutico-pazienti-covid-19\/","title":{"rendered":"Protocollo clinico e terapeutico pazienti covid-19"},"content":{"rendered":"<p><a href=\"https:\/\/www.inmi.it\/wp-content\/uploads\/2020\/04\/1-4-profli-COVID-19.pdf\">Quattro profili clinici per il triage e la corretta collocazione dei pazienti COVID-19<\/a><\/p>\n<p><a href=\"https:\/\/drive.google.com\/open?id=1xvnk0pSPL9D_VoPRzTSPZ927Xx_u64Xc\">Gestione clinica e terapeutica dei pazienti COVID-19 <\/a><\/p>\n<p><a href=\"https:\/\/www.inmi.it\/wp-content\/uploads\/2020\/04\/3-COVID-19-Protocollo-di-gestione-clinica-19-marzo.pdf\">3 COVID-19-Protocollo-di-gestione-clinica-19-marzo<\/a><\/p>\n<p><a href=\"https:\/\/www.inmi.it\/wp-content\/uploads\/2020\/04\/4-COVID-19-Allegato-1-13-marzo-2020.pdf\">Allegato 1: Lopinavir \/ritonavir: modulistica per autorizzazione al trattamento <\/a><\/p>\n<p><a href=\"https:\/\/www.inmi.it\/wp-content\/uploads\/2020\/04\/5-COVID-19-Allegato-2-13-marzo-2020.pdf\">Allegato 2: Modified early warning score (MEWS)<\/a><\/p>\n<p><a href=\"https:\/\/www.inmi.it\/wp-content\/uploads\/2020\/04\/6-COVID-19-Allegato-3-13-marzo-2020.pdf\">Allegato 3: Novel Coronavirus (nCoV) &#8211; Acute Respiratory Infection Clinical Characterisation Data Tool<\/a><\/p>\n<p><a href=\"https:\/\/www.inmi.it\/wp-content\/uploads\/2020\/04\/7-COVID-19-Allegato-4-13-marzo-2020.pdf\">Allegato 4: Report settimanale<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Quattro profili clinici per il triage e la corretta collocazione dei pazienti COVID-19 Gestione clinica e terapeutica dei pazienti COVID-19 3 COVID-19-Protocollo-di-gestione-clinica-19-marzo Allegato 1: Lopinavir \/ritonavir: modulistica per autorizzazione al trattamento Allegato 2: Modified early warning score (MEWS) Allegato 3: Novel Coronavirus (nCoV) &#8211; Acute Respiratory Infection Clinical Characterisation Data Tool Allegato 4: Report settimanale<\/p>","protected":false},"author":347,"featured_media":0,"parent":0,"menu_order":22,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","h5ap_radio_sources":[],"footnotes":""},"class_list":["post-9873","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.inmi.it\/pt\/wp-json\/wp\/v2\/pages\/9873","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.inmi.it\/pt\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.inmi.it\/pt\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.inmi.it\/pt\/wp-json\/wp\/v2\/users\/347"}],"replies":[{"embeddable":true,"href":"https:\/\/www.inmi.it\/pt\/wp-json\/wp\/v2\/comments?post=9873"}],"version-history":[{"count":5,"href":"https:\/\/www.inmi.it\/pt\/wp-json\/wp\/v2\/pages\/9873\/revisions"}],"predecessor-version":[{"id":10011,"href":"https:\/\/www.inmi.it\/pt\/wp-json\/wp\/v2\/pages\/9873\/revisions\/10011"}],"wp:attachment":[{"href":"https:\/\/www.inmi.it\/pt\/wp-json\/wp\/v2\/media?parent=9873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}